BioSpace News Archive

Genetown

Oncobindi Therapeutics: Precision Oncology Assets: Fast-Track Development from lead Candidate to Clinic

We are entering an era of rapidly evolving transformation in cancer treatment as it relates to drug development, and a shifting paradigm of standardized health care in which detailed genetic and molecular information regarding a patient’s cancer is being used for personalized precision treatments.

February 9, 2018

·

1 min read

Business

Peli BioThermal Joins Poseidon Sea Freight Program as Founding Member

Peli BioThermal, the global name in temperature controlled packaging, has announced their founding membership in Poseidon.

February 9, 2018

·

1 min read

Business

Novanta Schedules Earnings Release and Conference Call for Wednesday, February 28, 2018

Novanta will release its fourth quarter and full year 2017 results on Wednesday, February 28, 2018.

February 9, 2018

·

1 min read

Business

Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results

The company is hosting a conference call at 4:30 p.m. EST to discuss results.

February 9, 2018

·

5 min read

Deals

Vaxart Provides Merger Update

Vaxart announced today it has reached an understanding with the CAS Group under which East Hill, a major shareholder in Aviragen, will support the merger between Vaxart and Aviragen.

February 9, 2018

·

4 min read

Pharm Country

PAVmed Announces Completion of Offer to Exercise Series W Warrants at a Temporarily Reduced Price

PAVmed today announced the completion of its previously announced offer to exercise its publicly-traded warrants (the “Series W Warrants”) at a temporarily reduced exercise price of $2.00 per share.

February 9, 2018

·

4 min read

Business

Dynatronics Schedules Conference Call to Report Financial Results for Second Fiscal Quarter

Dynatronics today announced that its financial results for the quarter ended December 31, 2017 will be released post market close on Tuesday, February 13, 2018.

February 9, 2018

·

1 min read

Policy

Effectiveness in Preventing Non-Compliant or Fraudulent Products From Being Placed on the Market Is Questionable, Despite Notified Body Assessment, Says EU Medical Device Expert

CEO of the London-based medical device regulatory consultancy Quality First International - has written a critical examination of Commission Implementing Regulation No 920/2013 on audits and assessments by Notified Bodies.

February 9, 2018

·

1 min read

Business

Syneos Health Names Lisa van Capelle Chief Human Resources Officer

Syneos Health has announced the appointment of Lisa van Capelle as Chief Human Resources Officer.

February 9, 2018

·

2 min read

Zucara Therapeutics Receives Funding to Advance Lead Drug Candidate

Zucara recently defined its lead drug candidate, ZT-01, and this support will enable Zucara to conduct critical validation work and further advance ZT-01 through preclinical testing.

February 9, 2018

·

1 min read